Cost-Effectiveness Modelling of Sofosbuvir-Containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South Africa

被引:0
作者
Ilanca Fraser
Johanita Burger
Martie Lubbe
George Dranitsaris
Mark Sonderup
Tienie Stander
机构
[1] North-West University (Potchefstroom Campus),Medicine Usage in South Africa (MUSA), Faculty of Health Sciences
[2] Augmentium Pharma Consulting Inc.,Department of Medicine and Division of Hepatology
[3] University of Cape Town and Groote Schuur Hospital,undefined
[4] HEXOR (Pty) Ltd.,undefined
来源
PharmacoEconomics | 2016年 / 34卷
关键词
Sustained Virologic Response; Sustained Virologic Response Rate; Sofosbuvir; Early Virologic Response; Annual Transition Probability;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:403 / 417
页数:14
相关论文
共 156 条
[1]  
Abuelhasssan W(2012)Review: hepatitis C virus infection in 2012 and beyond South Afr J Epidemiol Infect. 27 93-97
[2]  
Karoney MJ(2013)Hepatitis C virus (HCV) infection in Africa: a review Pan Afr Med J. 14 44-25
[3]  
Siika AM(2013)The status of hepatitis C—the silent “volcano” in South Africa Commun Dis Surveill Bull. 11 22-605
[4]  
Prabdial-Sing N(1997)Hepatitis C virus infection rate in volunteer blood donors from the Western Cape — comparison of screening tests and PCR S Afr Med J. 87 603-12
[5]  
Puren A(2002)Viral hepatitis in South African healthcare workers at increased risk of occupational exposure to blood-borne viruses J Hosp Infect. 50 6-115
[6]  
Schoub B(2011)Evolving epidemiology of hepatitis C virus Clin Microbiol Infect. 17 107-S24
[7]  
Tucker TJ(2007)Natural history and predictors of disease severity in chronic hepatitis C J Hepatology. 44 S19-900
[8]  
Voight M(2011)Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more Clin Infect Dis. 52 889-1472
[9]  
Bird A(2012)Expanding access to treatment for hepatitis C in resource-limited settings: lessons From HIV/AIDS Clin Inf Dis. 54 1465-29
[10]  
Robson S(2007)Management of hepatitis C Prim Health Care. 17 25-S4